Schedule 13G ownership disclosure
LYRA THERAPEUTICS INC
Security class unavailable · CUSIP: 55234L105
Event date: 2022-04-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,780,261
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-095334
- Form type
- SC 13G
- Filer
- Lyra Therapeutics, Inc.
- CIK
- CIK 1327273
- Filed
- Aug 25, 2023
- Reporting period
- Apr 12, 2022
- Description
- Schedule 13G beneficial ownership